These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12446720)
1. Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines. Chen H; Toyooka S; Gazdar AF; Hsieh JT J Biol Chem; 2003 Jan; 278(5):3121-30. PubMed ID: 12446720 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. Chen H; Tu SW; Hsieh JT J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459 [TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Dote H; Toyooka S; Tsukuda K; Yano M; Ouchida M; Doihara H; Suzuki M; Chen H; Hsieh JT; Gazdar AF; Shimizu N Clin Cancer Res; 2004 Mar; 10(6):2082-9. PubMed ID: 15041729 [TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Yano M; Toyooka S; Tsukuda K; Dote H; Ouchida M; Hanabata T; Aoe M; Date H; Gazdar AF; Shimizu N Int J Cancer; 2005 Jan; 113(1):59-66. PubMed ID: 15386433 [TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Dote H; Toyooka S; Tsukuda K; Yano M; Ota T; Murakami M; Naito M; Toyota M; Gazdar AF; Shimizu N Br J Cancer; 2005 Mar; 92(6):1117-25. PubMed ID: 15770214 [TBL] [Abstract][Full Text] [Related]
6. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements. Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762 [TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis. Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. Nakayama T; Watanabe M; Suzuki H; Toyota M; Sekita N; Hirokawa Y; Mizokami A; Ito H; Yatani R; Shiraishi T Lab Invest; 2000 Dec; 80(12):1789-96. PubMed ID: 11140692 [TBL] [Abstract][Full Text] [Related]
11. Association of the variant rs2243421 of human DOC-2/DAB2 interactive protein gene (hDAB2IP) with gastric cancer in the Chinese Han population. Xu S; Zhou Y; Du WD; Chen G; Zhou FS; Schneider M; Ma XL; Xu HY; Zhang XJ Gene; 2013 Feb; 515(1):200-4. PubMed ID: 23246699 [TBL] [Abstract][Full Text] [Related]
12. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. Zhu X; Leav I; Leung YK; Wu M; Liu Q; Gao Y; McNeal JE; Ho SM Am J Pathol; 2004 Jun; 164(6):2003-12. PubMed ID: 15161636 [TBL] [Abstract][Full Text] [Related]
13. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168 [TBL] [Abstract][Full Text] [Related]
14. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer. Lee J; Lee MS; Jeoung DI; Kim YM; Lee H Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113 [TBL] [Abstract][Full Text] [Related]
17. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
18. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908 [TBL] [Abstract][Full Text] [Related]
19. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529 [TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Yuan BZ; Durkin ME; Popescu NC Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]